Apellis Pharmaceuticals | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Industry & Market
No industry information available
Funding Information
No funding information available
Headcount Distribution
No headcount data available
Department Breakdown
No department data available
Keywords & Focus Areas
No keywords available
Overview
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company founded in 2009 and based in Waltham, Massachusetts. The company specializes in developing targeted therapies that inhibit the complement system, particularly the C3 protein, to treat diseases caused by immune overactivation. Apellis has made significant strides in complement science, focusing on delivering innovative therapies for rare diseases.
The company has successfully brought two first-in-class C3-targeting medicines to market. Empaveli™ (pegcetacoplan) was approved by the FDA in 2021 for paroxysmal nocturnal hemoglobinuria (PNH), and Syfovre™ (pegcetacoplan injection) received FDA approval in 2023 for geographic atrophy (GA), a major cause of vision loss. Apellis is committed to advancing its pipeline of complement-based treatments to improve patient care and address unmet medical needs. Under the leadership of its founders, Apellis emphasizes a culture of inclusivity and corporate responsibility, focusing on patient access and environmental sustainability.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to
Compare insights from companies similar to , focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxx | $11087 | 110 | Private | - | 1915 | xxxxxxx |
| xxxxxxxxxx | $97269 | 6 | Private | - | 2430 | xxxxxxxx |
| xx | $89779 | 13 | Private | - | 8098 | xxx |
| xxxxx | $53085 | 147 | Private | - | 8348 | xx |
| xxxxxxxxx | $92099 | 77 | Private | - | 3568 | x |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.